Zobrazeno 1 - 10
of 59
pro vyhledávání: '"Hideki Murata"'
Autor:
Michihito Miyagi, Hirohisa Katagiri, Hideki Murata, Junji Wasa, Toshiaki Takahashi, Haruyasu Murakami, Hideyuki Harada, Keita Mori, Mitsuru Takahashi
Publikováno v:
BMC Pulmonary Medicine, Vol 22, Iss 1, Pp 1-11 (2022)
Abstract Background Despite improvement in the overall survival of patients with non-small cell lung cancer (NSCLC) harboring epidermal growth factor receptor (EGFR) mutation, the effects of EGFR tyrosine kinase inhibitor (EGFR-TKI) treatment on bone
Externí odkaz:
https://doaj.org/article/a4a305f11e8f4bd5b3e6d959ac91ff8b
Autor:
Hirohisa Katagiri, Mitsuru Takahashi, Hideki Murata, Junji Wasa, Michihito Miyagi, Yosuke Honda
Publikováno v:
BMC Surgery, Vol 22, Iss 1, Pp 1-8 (2022)
Abstract Background Chondroblastomas are rare, benign, locally aggressive lesions that appear in the epiphysis. Surgery for femoral head chondroblastoma (FHCB) is difficult. Conventional treatment with curettage via a drilled tunnel along the femoral
Externí odkaz:
https://doaj.org/article/8f47cf89c72d4b9d90a0a846ab680070
Autor:
Ryusuke Hatae, Nobuhiro Hata, Koji Yoshimoto, Daisuke Kuga, Yojiro Akagi, Hideki Murata, Satoshi O Suzuki, Masahiro Mizoguchi, Koji Iihara
Publikováno v:
PLoS ONE, Vol 11, Iss 8, p e0160489 (2016)
High resolution melting (HRM) is a simple and rapid method for screening mutations. It offers various advantages for clinical diagnostic applications. Conventional HRM analysis often yields equivocal results, especially for surgically obtained tissue
Externí odkaz:
https://doaj.org/article/8adb324a64ea4898b335822fae8e928a
Autor:
Tatsuya Takagi, Hirohisa Katagiri, Yongji Kim, Yoshiyuki Suehara, Daisuke Kubota, Keisuke Akaike, Midori Ishii, Kenta Mukaihara, Taketo Okubo, Hideki Murata, Mitsuru Takahashi, Kazuo Kaneko, Tsuyoshi Saito
Publikováno v:
PLoS ONE, Vol 10, Iss 6, p e0129428 (2015)
Skeletal metastasis is a common metastatic event for several carcinomas, and the treatment for skeletal metastasis of unknown primary (SMUP) are a critical issue in cancer therapy. Making a diagnosis of the primary site is the most crucial step in th
Externí odkaz:
https://doaj.org/article/9a41f604ef774636b6c05e4f02a7f708
Autor:
Yuya Makiguchi, Shinya Nagata, Takahito Kojima, Masaki Ichimura, Yoshifumi Konno, Hideki Murata, Hiroshi Ueda
Publikováno v:
PLoS ONE, Vol 4, Iss 6, p e5993 (2009)
Cardiac arrest caused by startling stimuli, such as visual and vibration stimuli, has been reported in some animals and could be considered as an extraordinary case of bradycardia and defined as reversible missed heart beats. Variability of the heart
Externí odkaz:
https://doaj.org/article/081a20e91026427f9ea53cf9bbc6f77e
Autor:
Hideki Murata, Michihito Miyagi, Hirohisa Katagiri, Yuji Ishida, Junji Wasa, Chiao Yee Lim, Mitsuru Takahashi
Publikováno v:
Journal of Orthopaedic Science. 27:943-948
Autor:
Toshiyuki, Amano, Akira, Nakamizo, Hideki, Murata, Yuichiro, Miyamatsu, Fumihito, Mugita, Koji, Yamashita, Tomoyuki, Noguchi, Shinji, Nagata
Publikováno v:
Cureus.
Objective Preoperative diagnosis of tumor grade can assist in treatment-related decision-making for patients with intracranial meningioma. This study aimed to distinguish between high-grade and low-grade meningiomas using conventional CT and MRI. Met
Publikováno v:
Jornal dos Comitês. 6
Autor:
Hirohisa Katagiri, Mitsuru Takahashi, Hideki Murata, Junji Wasa, Michihito Miyagi, Yosuke Honda
Publikováno v:
BMC surgery. 22(1)
Background Chondroblastomas are rare, benign, locally aggressive lesions that appear in the epiphysis. Surgery for femoral head chondroblastoma (FHCB) is difficult. Conventional treatment with curettage via a drilled tunnel along the femoral neck can
Autor:
Ichiro Ito, Hideki Murata, Seiichi Hosaka, Ken Yamaguchi, Mitsuru Takahashi, Yukihiro Matsuyama, Koji Muramatsu, Tohru Mochizuki, Hirohisa Katagiri, Yuji Ishida, Yosuke Honda, Junji Wasa
Publikováno v:
International Journal of Clinical Oncology. 24:1468-1478
Pro-gastrin-releasing peptide (ProGRP) is an established tumor marker of small cell lung cancer. The purpose of this study was to determine if ProGRP could serve as a tumor marker for the Ewing sarcoma family of tumors (ESFTs). Sixteen patients with